Home

PATRICK J MCENANY

CIK 929985 · President and CEO · last filed 2026-07-17

PATRICK J MCENANY is a President and CEO who has filed 112 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider disposed of $131.4M of CPRX on Jul 17, 2026. Across all open-market trades the lifetime net is −$51.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $401.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$401.5K

Companies

2

Total Filings

112

Lifetime Open-Market Net

-$51.57M

Filer Profile

Reported Address
C/O THERMOGENESIS CORP
2711 CITRUS ROAD
RANCHO CORDOVA, CA 95742
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Director 145,922 $31.49 $4.60M -$51.60M 90 2026-07-17
KOOL Director 27,039 $14.85 $401.5K $27.8K 14 2014-07-02

Recent Filings

112 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-17 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Disp (D) −4,171,559 -$131.40M EDGAR
2025-12-30 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Mixed +19,548 $0 EDGAR
2025-12-10 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Exer (M) +3,534 $0 EDGAR
2025-12-03 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Gift (G) −135,000 $0 EDGAR
2025-11-24 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Mixed +1,775 $0 EDGAR
2025-06-10 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Sell (S) −200,000 -$5.22M EDGAR
2025-06-06 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Notice (144) −200,000 -$5.18M EDGAR
2024-12-11 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Exer (M) +3,533 $0 EDGAR
2024-11-25 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Grant (A) — $0 EDGAR
2024-11-21 CATALYST PHARMACEUTICALS, INC. (CPRX) Delisted Mixed — -$3.02M EDGAR
Showing 1–10 of 112
Page 1 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.